Analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
Get Our Latest Stock Analysis on SenesTech
SenesTech Trading Up 6.9 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Best Aerospace Stocks Investing
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Learn Technical Analysis Skills to Master the Stock Market
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
